Abaxis Veterinary Reference Laboratories Now Offering Quantitative Lyme Test

Abaxis, Inc. ABAX announced today its Abaxis Veterinary Reference Laboratories Division, based in Olathe, Kansas, is now offering a quantitative antibody test for canine Lyme disease. The new canine Lyme test invented and developed by Abaxis, Inc., measures a combination of antibodies to peptides which mimic certain antigens of the Borrelia burgdorferi spirochete. These antibodies are not found in vaccinated or non-infected patients. Dr. Kenneth Aron, Chief Technology Officer at Abaxis, commented, "We have utilized advances in peptide chemistry and immunology to design a robust laboratory-based test that can distinguish an active Lyme infection from immunity based on vaccination. These advances allow a definitive diagnosis which is required for reference laboratory performed confirmation test."